JPS5813516A - Preparation of amebocyte lysate - Google Patents

Preparation of amebocyte lysate

Info

Publication number
JPS5813516A
JPS5813516A JP56111339A JP11133981A JPS5813516A JP S5813516 A JPS5813516 A JP S5813516A JP 56111339 A JP56111339 A JP 56111339A JP 11133981 A JP11133981 A JP 11133981A JP S5813516 A JPS5813516 A JP S5813516A
Authority
JP
Japan
Prior art keywords
lysate
liquid containing
endotoxin
amebocyte lysate
fraction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP56111339A
Other languages
Japanese (ja)
Other versions
JPH0324628B2 (en
Inventor
Sadaaki Iwanaga
岩永 貞昭
Takashi Morita
隆司 森田
Shigenori Tanaka
重則 田中
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Seikagaku Corp
Original Assignee
Seikagaku Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seikagaku Corp filed Critical Seikagaku Corp
Priority to JP56111339A priority Critical patent/JPS5813516A/en
Publication of JPS5813516A publication Critical patent/JPS5813516A/en
Publication of JPH0324628B2 publication Critical patent/JPH0324628B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

PURPOSE:To obtain the titled substance having a high specificity of endotoxin or a liquid containing the titled substance, by removing a nonendotoxic coagulating enzymic precursor activating factor from amebocyte lysate of a horse crab or a liquid containing it. CONSTITUTION:Ambocyte lysate of a horse crab or a liquid containing it is subjected to the liquid chromatography with a heparin agarose as an adsorption carrier and a salt solution having an ionic strength of 0.15-0.45M as an eluting solution to remove a nonendotoxic coagulating enzymic precursor activating factor capable of causing the coagulating reaction of amebocyte lysate even in the absence of endotoxin by activation with a beta-1, 3-glucan, and give an amebocyte lysate useful in the limulus test in the field of medical science or pharmacology or a liquid containing the amebocyte lysate.

Description

【発明の詳細な説明】 本発−は、アメボサイト・ライゼートの精製法に関し、
さらに詳しくは、カブトガ=OJllllンパ液よ如取
得されるアメポナイトO゛抽#At(アメポナイF−2
イゼート)から不純物を除去して、エンドトキシン特異
性が高いアメダナイト・ライゼートを調製する方法に係
る。
[Detailed Description of the Invention] The present invention relates to a method for purifying amebosite lysate,
For more details, see Ameponite O゛Bullet #At (Ameponai F-2
The present invention relates to a method for preparing amedanite lysate with high endotoxin specificity by removing impurities from lysate.

カブトガ= (Llmmlms p@1yph@a+m
s 、丁a*hypl−・ws trLd@mtatw
s、 T、 gigas等)0皇リンパ液に存在するア
メytイト・に対すゐグラム陰性画表層物質1エンドト
キシン1(ツボ・ポリナラカライド)の作画によ)生起
するカブトガニ皇りンパ液凝lI現象は、生体防禦機構
の−から。
Kabutoga = (Llmmlms p@1yph@a+m
s, choa*hypl-・ws trLd@mtatw
s, T, gigas, etc.)0 A gram-negative image of amytite present in the lymph fluid.A gram-negative surface substance1. is from the biological defense mechanism.

興味欅(研究されている。一方、アメボナイト・ツボ−
に’−)0.エントド命シンによる凝1iisi象は、
″リムルステスト1の一般本でエンドトキシン特異的検
出法として医学、薬学の領域において広く利用されてい
る。アメボサイト・ライゼートのゲル化を起す物質とし
て、工ンドト今シンを論いて、哺乳動物等oaIIJl
&酵素(トリグシン、トロンビン等)がカブトガニ凝−
系鎖似酵素として知られてはい為ものの、これらII)
III以外には見−出せないことから、リムルス・テス
トはエンドトキシンの善異約反応系として評価されて来
え。
Interest (being researched. On the other hand, amebonite acupuncture points
ni'-)0. The first impression by Entodo Life Shin is,
``This is a general book on Limulus Test 1, which is widely used in the medical and pharmaceutical fields as an endotoxin-specific detection method.It discusses endotoxin as a substance that causes gelation of amebocyte lysate, and uses it in mammals, etc.
& Enzymes (trigsin, thrombin, etc.)
These II) are known as chain-like enzymes.
Since it has not been found anywhere other than III, the Limulus test has been evaluated as a good allotropic reaction system for endotoxin.

本実−者らは、アメブナイト・ライゼートの凝−機構の
解明につ自鋭意研究を行ってき大過−で、カブトガニの
凝−系に係る酵素に41異的な含酸基質を用いる高感度
且つ走置性の高いエントド中シン検出−冑法(41m1
1i1$4−1197参隔)を11&供すると共にアメ
ブナイト・ライゼートの凝−機@に於てエンドトキシン
が直接作用する物質は、従来よ如言及されて−る凝−酵
素前駆体では倉〈、倫にエンドトキシン感受性1 物質が存在し、エントド命゛シンの作用によ)それが活
性化を受け1次%Aで皺閣酵素曽皐体を、活性を有すみ
凝−酵素とし、かくして活性化され大−嵩の働きによ)
コアギ3−W−ダンが繊維状ツアギエ啼ンとなること、
すなわちカブトガニomits系も、哺乳動物と同様 
多数酵素詳0段階的反応によ)凝−が進む系であること
を1111し一!  (F@bs、L@tt@rs、1
20 217  (198G)S、Ivaaaga・t
al)。
The authors have been conducting extensive research to elucidate the coagulation mechanism of amebunite lysate, and have developed a highly sensitive and highly sensitive method using 41 different acid-containing substrates for enzymes involved in the coagulation system of horseshoe crabs. Detection of highly traversable Entodium Synths--Method (41m1)
1i1$4-1197 11&, and the substances on which endotoxin acts directly in the amebunite lysate coagulant are the coagulant enzyme precursors previously mentioned. Endotoxin susceptibility 1 A substance is present, and it is activated (by the action of endotoxin) and becomes an active coagulant enzyme, and is thus activated and becomes a highly active coagulase. - due to bulk)
Koagi 3-W-Dan becomes a fibrous tsuagie,
In other words, the horseshoe crab omits system is similar to mammals.
1111 that it is a system in which condensation (due to a stepwise reaction involving multiple enzymes) proceeds! (F@bs, L@tt@rs, 1
20 217 (198G) S, Ivaaaga・t
al).

本発明者らは、上記O事実に加えて°、更に1次OIl
親事実な見出し本発−に真速した。すなわち、アメボテ
イト・ライゼートに作用して皺ツイゼートをゲル化せし
める物質としてエンドトキシン011に/−1,!l−
艙舎含有するグルーース・ポリマー及びその誘導体が存
在することを始めて確認し、アメポナイト・ライゼート
中にはこれらの物質によ)作用を受ける/−1,1−ダ
ルカン感受性因子が存在し、この画分はエントド中シン
感受性物質画分とは異なることを見−出しえ。
In addition to the above facts, the present inventors further discovered that the primary OIl
I ran straight into the obvious headline. In other words, endotoxin 011 is a substance that acts on amebotate lysate to gel it./-1,! l-
We confirmed for the first time the existence of glucose polymers and their derivatives contained in the ameponite lysate, and found that -1,1-dalcane-sensitive factors that are affected by these substances exist in ameponite lysate, and that this fraction It was found that this fraction differs from the syn-sensitive substance fraction in Entodo.

本Il@は、?−れらアメポナイト・ライ(−ト□、。What is the book Il@? -Rera Ameponite Rai (-to □,.

中07−1.3−グルカン及びその誘導体に感受性を有
し、エンドトキシン0非存在下に於てもアメブナイト・
クィゼートOa固反応を起す物質(画分)を除去するこ
とによ〕エンドトキシンに対し特異性の^いアメブナイ
ト・ライゼートを提供するととに係る。
Sensitive to 07-1.3-glucan and its derivatives, even in the absence of endotoxin 0.
The purpose of this invention is to provide an amebunite lysate that is specific to endotoxin by removing substances (fractions) that cause a quisate Oa solid reaction.

本1llq40/−1.3−グルカン感受性画分は、リ
ムルス・ポ97エムス、及びタキプロイス・トシデンタ
タス等O★ブドーJI工・アメブナイト・94イートヲ
ヘパリン・セファレースCL−610(Pharma山
Fine Chemicals社、スエーデン)のごと
きヘパリン結合架橋アガロース・ゲルを吸着担体として
執着液体クロマジグラフイーな行うときイオン強j10
.15M−0,5MO塩St好ましくは塩化ナシリウム
濤液を用いて吸着担体から脱離溶出される。
This 1llq40/-1.3-glucan-sensitive fraction contains Limulus po97ems, Tachyplois tocidentatus, etc. When performing liquid chromatography using a heparin-bonded cross-linked agarose gel as an adsorption carrier, such as
.. The 15M-0,5MO salt St is preferably desorbed and eluted from the adsorption carrier using a sodium chloride solution.

この両分に7−1.3−グルカンを加えてインdPj−
ベートし次いで、凝固酵素前駆体画分を加えるとき凝1
1酔素前駆体は活性化を受はコアギエロダン中コアギエ
ロゲンO構造から調整され大息色性合成基質Iliに作
用し、ゲル化するか。
Add 7-1,3-glucan to both of these to make indPj-
When the coagulation enzyme precursor fraction is added, the coagulation 1
The mono-intoxicant precursor undergoes activation and is adjusted from the coagielogen O structure in the coagielodan, acts on the hyperchromic synthetic substrate Ili, and gels.

又は発色する。この/−1,3−グルカン感受性画分の
存在は本発明者らが始めて明らかにしえものであり1本
発明者らの検討によ#)、アメポナイト・ライ(−トを
セファクリル”S−200(ファルマシア・ファインケ
ンカルス社)セルミツアイy@Gc−200(チッソ(
株))等O通常の分子篩ターマドグツフィーによっても
分画することが出来る。本発明01的はカブ・トガ=0
アメポナイト・ライゼート中の/−1,3−グルカン感
受性画分を除去することkよってエンドトキシン・スベ
シアイツクなアメブナイト・ツィゼー)#lI#&供す
る仁とであるから、 /−1,3−グルカン感受性画分
の確認法に関しては本発明の実施例に限定されるもので
はない。
Or develop color. The present inventors were the first to clarify the existence of this /-1,3-glucan-sensitive fraction. (Pharmacia Finekencals) Selmitsai y@Gc-200 (Chisso (
It can also be fractionated using ordinary molecular sieves such as termed sieves. The present invention 01 is turnip toga = 0
By removing the /-1,3-glucan-sensitive fraction in the ameponite lysate, the /-1,3-glucan-sensitive fraction is removed. The confirmation method is not limited to the embodiments of the present invention.

本発明fDII−1,3−グルカンは、コンブ(La−
mlmaria)bアツメjlis@mIm )等01
1111類から得られるツ建ナリン(Lamlmarl
m )や、ブタ9Wつ(P@mia・・@wsO曹核)
から得られるパキマン(Paskygmam )が適用
されパ命マン等では水篩性を増す為にム、 L C1a
rk@! Fhyt@曾hemIstry 1175〜
18g (1967)0手法KN−力k & 中/メチ
ル化−導体として使用しても、いずれも/−1,3−ダ
ルカン感受性因子を活性化することが確■される。
The fDII-1,3-glucan of the present invention is derived from kelp (La-
mlmaria)bAtsumejlis@mIm)etc.01
Tsukennarin (Lamlmarl) obtained from Class 1111
m) and 9W pigs (P@mia...@wsO Sokoku)
Paskygmam obtained from Paskygmam is applied to Paskygmam etc. to increase water sieving property, L C1a
rk@! Fhyt@senghemIstry 1175~
18g (1967) 0 method KN-force k & medium/methylation- even when used as a conductor, both are confirmed to activate /-1,3-darcan-sensitive factors.

以下1本発−を、調側例、!I!施例によ)さらKA体
的Kl!明する。
The following one shot is an example of the key side! I! According to the example) KA physical Kl! I will clarify.

*会mI!1−4013140方mK皐Cfi本jll
#ブトj工(Ta@kypl働ws trtd@mts
tws) (体重約!〜)から、厳重に汚染を避けて、
豹loo―の皇リンパ液を採取しえ、遠心分−によ勤、
アメがナイトを分離し、3%塩化ナトリウム**で洗−
しアメポナイト・ペレットを得九〇このアメがサイト・
ベレッ) K O,OSM Trla−ICj Ilw
−ff@r、 pm ’1.2を原車りンパ液の1/i
o春加え、滅菌し光ホ毫ジナイず−でよく攪拌し、 8
.Goer陣で30分関達心後、その上清をもってアメ
ボナイト・2イゼー)TTLとした。
*Meeting! 1-4013140mK甐Cfi本jll
# Butoj engineering (Ta@kyplworking ws trtd@mts
tws) (weighs approximately! ~), strictly avoid contamination,
Collect the leopard's lymph fluid and centrifuge it.
Separate the candy and night and wash with 3% sodium chloride**.
You can get 90 Ameponite pellets from this site.
Beret) K O, OSM Trla-ICj Ilw
-ff@r, pm '1.2 to 1/i of the original car lymph fluid
Add o spring, stir well with a sterilized light powder, 8
.. After stirring for 30 minutes in Goer's group, the supernatant was used as Amebonite 2 Ize) TTL.

調製例27メ9力童カブ訃ガニ(Limmlwsp・t
ypb・鵬−)アメIナイト・ツイゼ−)0$1931 調製例1と同様の操作によりアメボサイト・ツイゼー)
LPLとした。
Preparation Example 27Me9 Turnip Dead Crab (Limmlwsp・t
ypb・Peng-) Ame I Night Twize-) 0$1931 Amebosite Twize) was prepared by the same procedure as Preparation Example 1.
It was set as LPL.

調製 プタリ璽つから*  Y* 8hlbata、 J、 
F@rm@nt。
Preparation putari jitsukara* Y* 8hlbata, J,
F@rm@nt.

丁eek@@1..60388 (1972)0方法に
従−1pm@b−ymamを間開しDMSOを用いて精
製しs AK @ C1a rk@ ePbyte@h
@m1stry 1.157〜18g (1967)の
方法で★ルポキシメチル化してCMPを得た。
Dingeek@@1. .. 60388 (1972) 0 method, -1pm@b-ymam was cleaved and purified using DMSO.
@m1stry 1.157-18g (1967) was used to perform *lupoxymethylation to obtain CMP.

調製例1 テ得らtL光T T L S 0111#t
O,O5MTrI s −HCj elk II IE
 PH’I−2を用いて3倍に希釈し先に岡−緩1i1
1にてコンデシlユング(緩衝化)したヘパリンセファ
ロースCL−6B:JF9ム(10xl?as)Kかけ
た。溶離操作を次のステップで打電った。すなわち。
Preparation Example 1 TTL Light TTL S0111#t
O,O5MTrI s -HCj elk II IE
Dilute 3 times using PH'I-2 and first add Oka-Yu 1i1.
Heparin Sepharose CL-6B:JF9 (buffered) at 1:1 was applied. The elution operation was performed in the following steps. Namely.

■カラムコンデシ曹二ング緩衝液を用いて11I崗し、
AK1分を得た。
■ Column conditioning using 11I buffer solution,
Obtained AK1 minute.

■0.ISMNaCjを用いて溶出し、6画分を得え。■0. Elute using ISMNaCj to obtain 6 fractions.

■046MNaCノを用いて濶出し8画分を得え。■Obtain 8 fractions using 046MNaC.

これら0画分を本尭明看らが先に報告した手法(F@b
s L@tt@rs ■1217−220 (1980
)、S。
These 0 fractions were analyzed using the method previously reported by Akika Motoya et al. (F@b
s L@tt@rs ■1217-220 (1980
), S.

Iwamaga @t al)を用いてそam出画分の
性質を1〜70構成試験を行いその結果を第1I!及び
第2表に示し良。第111紘、画分A、G及びSを再び
組会わせml、*・110111−14エンドトキシン
の存在下で行なった実験及びその結果を示すものであシ
、第3表辻−分A、G及びbを再び腫合わせ、カルボ中
ジメチル化され九(l→3)−7−D−ダルカン(CM
P S )の存在下で行なり良実験及びその結at示す
亀のである・実験は1次のようにして行なった。
Iwamaga@tal) was used to conduct 1 to 70 configuration tests on the properties of the fractions extracted from the air, and the results were reported in the 1st I! and good as shown in Table 2. This is an experiment conducted in the presence of endotoxin by recombining fractions A, G, and S, *110111-14, and the results thereof. and b were combined again to form dimethylated 9(l→3)-7-D-dulcan (CM
The experiment was carried out in the presence of P S ) and its results are shown.The experiment was carried out as follows.

5oisノO各分画、エンドトキシン又はCMP(最終
濃11! 2407m1) 、04mMの発色性口質。
5 ois each fraction, endotoxin or CMP (final concentration 11!2407ml), 04mM chromogenic oral fluid.

110mM()Trls−HCJ ()リス−塩酸)緩
miml(pig s畠、0)及び5.2閣Mの塩化!
グネシウム(MgC鳥)を含み1食害量−IIA!50
sjO反応箪を3フCで30分間イン中エベート(装置
)した0次に、 o、s mo 0、6 M酢酸を加え
て反応を停止し、 405mmKおける1光度を測定し
た。構成実験KThいて&冬。
110mM ()Trls-HCJ ()Lis-HCl) mild miml (pig s Hatake, 0) and 5.2 KM chloride!
Contains gnesium (MgC bird) 1 feeding damage amount - IIA! 50
The sjO reaction chamber was incubated at 3 °C for 30 minutes. Next, 6 M acetic acid was added to stop the reaction, and the luminous intensity at 405 mmK was measured. Composition experiment KTh & winter.

ム、ByLはCO各画分5osiを互vhK混合し。For ByL, 5osi of each CO fraction was mixed with vhK.

上記し九と同じ条件下でアミ〆−(活性を一定し光、会
画分のタロットー形成能は高置に精製し大コアギエログ
ンを用9A、次Oよう°にして一定した0反応楓金物は
、各分画A、Blび0%しくはそれらを組合わせ良梶合
物!!OjJ、CMPI(400mf/5d)30μノ
、夕今プリクス(Ta*hyp鳳・l);アギエロゲン
(2q/W11)100#jjhよび26−MgCJ、
を會む0.4M)リスー塩酸緩1111(PII8.O
)を會み、全容は3!30μノであった。り■ットが3
7Cで1時間以内Kllわれ大鳩舎、試料は陽性の反応
を示すものと判断しえ。
Under the same conditions as in 9 above, the activity was kept constant, and the tarot-forming ability of the reaction fraction was purified at a high temperature, and the large core agielogne was used at 9A, then at 0 °C to maintain a constant 0 reaction. , each fraction A, Bl and 0% or a good combination of them! ) 100#jjh and 26-MgCJ,
0.4M) Lys-hydrochloric acid 1111 (PII8.O
), and the total size was 3!30μノ. Rit is 3
If the large pigeon coop is incubated at 7C for less than 1 hour, the sample is considered to have a positive reaction.

第  1II I       A          O−−2G 
          O− 4ム十G         O− 5A+Il    326       +1!   
 G+Il     414          +7
  A十〇+1  662       +第  2I
I (XIG”’) I       A          O−2G 2
84 十 3      B           Q     
        −4A+G      455   
         +5     A+I      
  O−g     G+il      373  
          +7   A+G十8  491
        十B共単独では凝固酵素活性(ア電ダ
ーイ活性)を示さないが、エンドトキシンの作用を受は
九Bと共同したムは凝1iIWII嵩活性を生ずる。然
し。
1III IA O--2G
O- 4mu 10G O- 5A+Il 326 +1!
G+Il 414 +7
A〇+1 662 + 2nd I
I (XIG”') I A O-2G 2
84 13 B Q
-4A+G 455
+5 A+I
O-g G+il 373
+7 A+G18 491
10B alone does not exhibit clotting enzyme activity (Adendai activity), but when subjected to the action of endotoxin, 9B together with 9B produces coagulation 1iIWII bulk activity. However.

/−1,3−グルカンの作用を受けてAo、b共。/- Both Ao and b are affected by the action of 1,3-glucan.

単独でも、共同しても凝固酵素活性を示さ′&い。They exhibit clotting enzyme activity either alone or in combination.

G画分は/−1,3−グルカンの1作用を受けて凝固酵
素活性を発現する。これらのことからヘパリン−セファ
ロース・CL6B4Da着クロマトダツりイーにより 
−0,15M〜0.45M NaCJで脱着される両分
はエンドトキシンに感受性の無いI−1,3−グルカン
感受性画分であることが判る・、ζ ツフイ 調製例2のL P 50−を43X114−のS*ph
aeryls −zooカツムを用いてゲルー過を実施
しえ。
The G fraction expresses coagulase activity under the action of /-1,3-glucan. For these reasons, heparin-Sepharose/CL6B4Da-attached chromatography
It can be seen that both fractions desorbed by -0,15M to 0.45M NaCJ are I-1,3-glucan-sensitive fractions that are not sensitive to endotoxin. -S*ph
Gel filtration can be performed using aeryls-zoo Katsum.

そのクロマトグラムを図に示す、各両分は実施例1の構
威夾験方法に従って性質を明らかにし。
The chromatogram is shown in the figure, and the properties of each component were clarified according to the construction experiment method of Example 1.

対応するA、B及びG画分として示し* @ NaCノ
両分はカラムボリュームに対応する位置の電気伝導度か
ら算出した。B画分はS@ph畠*ryl S−200
に吸着性を示しNaCj Kよ)si出され大と考えら
れる。
Shown as corresponding A, B and G fractions *@NaC fractions were calculated from the electrical conductivity at the position corresponding to the column volume. B fraction is S@ph Hatake*ryl S-200
It is thought that it shows adsorption to NaCj (K) and releases a large amount of Si.

【図面の簡単な説明】[Brief explanation of the drawing]

図は% S@pha*ryl S−200カラムを用い
たゲル濾過法によるアメボサイト・ライゼー)LPのク
ロマトグラムである。 0−OA画分 ・−・ B画分 Δ−−−Δ G画分 NaCJ画分
The figure is a chromatogram of Amebosite lysae) LP obtained by gel filtration using a %S@pha*ryl S-200 column. 0-OA fraction --- B fraction Δ --- Δ G fraction NaCJ fraction

Claims (1)

【特許請求の範囲】[Claims] (1)  ★ブトガニ・アメポナイト・ライゼート又は
それを含む液体から非エンドトキシン性凝−−嵩前駆体
活性化因子を除去することを特徴とするエントド中シン
K”41異的なアメポナイト・ツボ(−ト又はそれを含
む液体OII員繊・ 働 非エンドトキシン性凝−−嵩前鳳体活性化膿子が/
−1,3−ダルカン111によIJ添性化されるもO′
cあることを411像とする特許請求の聰■嬉Ill記
載OII調法。 al−jIブトS工・アメボナイト・ライゼート叉はそ
れを含む筐体をヘパ曹ン・アガ四−スを執着担体とLイ
オン強直(LIBM〜叡4$MO塩S*を一一筐とする
液体りE1マトダツフイーに付し、非エントド命シン性
凝−−嵩飾駆体活性化因子を含む一分を除去することを
特徴とする特許請求の範囲第1項記載の調製法。
(1) ★A unique ameponite acupoint (-toxin) characterized by the removal of non-endotoxic coagulation bulk precursor activating factors from staghorn crab ameponite lysate or liquids containing it. or a liquid containing the same.
-1,3-Dulcan 111 adds IJ to O'
The OII method described in the patent claim that uses the fact that there is c as a 411 image. AL-JI buto S engineering, amebonite, lysate, or a liquid containing hepatic acid and aga4 as an attachment carrier and L ion tonicity (LIBM~EI4$MO salt S* as a single case) 2. The preparation method according to claim 1, which comprises subjecting the sample to E1 to remove a portion containing a non-enzymatic coagulation-decorating precursor activator.
JP56111339A 1981-07-16 1981-07-16 Preparation of amebocyte lysate Granted JPS5813516A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP56111339A JPS5813516A (en) 1981-07-16 1981-07-16 Preparation of amebocyte lysate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56111339A JPS5813516A (en) 1981-07-16 1981-07-16 Preparation of amebocyte lysate

Publications (2)

Publication Number Publication Date
JPS5813516A true JPS5813516A (en) 1983-01-26
JPH0324628B2 JPH0324628B2 (en) 1991-04-03

Family

ID=14558683

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56111339A Granted JPS5813516A (en) 1981-07-16 1981-07-16 Preparation of amebocyte lysate

Country Status (1)

Country Link
JP (1) JPS5813516A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047353A (en) * 1988-03-16 1991-09-10 Wako Pure Chemical Industries, Ltd. Process for preparing reagent for measuring endotoxin
WO1992003736A1 (en) * 1990-08-22 1992-03-05 Seikagaku Kogyo Kabushiki Kaisha Assaying agent for endotoxin
US5179006A (en) * 1988-02-27 1993-01-12 Wako Pure Chemical Industries, Ltd. Process for measuring endotoxin
JPH0578727U (en) * 1992-02-20 1993-10-26 ニチアス株式会社 Fireproof partition wall
US5605806A (en) * 1990-08-22 1997-02-25 Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation) Reagent for assaying endotoxin

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57108018A (en) * 1980-07-16 1982-07-05 Seikagaku Kogyo Co Ltd Endotoxin-sensitive substance

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57108018A (en) * 1980-07-16 1982-07-05 Seikagaku Kogyo Co Ltd Endotoxin-sensitive substance

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5179006A (en) * 1988-02-27 1993-01-12 Wako Pure Chemical Industries, Ltd. Process for measuring endotoxin
US5318893A (en) * 1988-02-27 1994-06-07 Wako Pure Chemical Industries, Ltd. Process for measuring endotoxin
US5047353A (en) * 1988-03-16 1991-09-10 Wako Pure Chemical Industries, Ltd. Process for preparing reagent for measuring endotoxin
WO1992003736A1 (en) * 1990-08-22 1992-03-05 Seikagaku Kogyo Kabushiki Kaisha Assaying agent for endotoxin
US5605806A (en) * 1990-08-22 1997-02-25 Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation) Reagent for assaying endotoxin
JPH0578727U (en) * 1992-02-20 1993-10-26 ニチアス株式会社 Fireproof partition wall

Also Published As

Publication number Publication date
JPH0324628B2 (en) 1991-04-03

Similar Documents

Publication Publication Date Title
Martin et al. The chromatographic fractionation of ribonuclease
US5658548C1 (en) Nucleic acid purification on silica geland glass mixtures
JP3217286B2 (en) DNA immobilized complex
Danishefsky et al. Synthesis of heparin-sepharoses and their binding with thrombin and antithrombin-heparin cofactor
Lock et al. Rapid analysis of tetracycline antibiotics by combined solid phase microextraction/high performance liquid chromatography/mass spectrometry
Danishefsky et al. Preparation of heparin-linked agarose and its interaction with plasma
JP3402476B2 (en) Lipopolysaccharide binding protein and method for producing the same
JPS5813516A (en) Preparation of amebocyte lysate
US4380511A (en) Purification of bovine thrombin
Akagi et al. Purification and properties of acid ribonucleases in human serum and leukocytes
JPS62258326A (en) Purification and solubilization of protein antigen, detoxification of bordetella pertussis toxin and cell free pertussis vaccine
Branson et al. Prothrombin time after heparin removal: Application to monitoring simultaneous anticoagulation with heparin and coumarins
Nagashima et al. Coagulating effect on calcium carbonate of sulfated glycoproteins isolated from pathological human bile
JPH02138193A (en) Amebocyte lysate having high specificity to beta-glucans and production thereof
JPH02193913A (en) Removal of pyrogen
Kong et al. Development of a DNA immunoadsorbent: coupling DNA on sepharose 4FF by an efficient activation method
JPS5813517A (en) Inhibitory factor on coagulation present in amebocyte lysate of horse crab
JPS596883A (en) Method for concentrating and purifying human uric callicrein
RU2665165C1 (en) Method for producing an immunosorbent
JPS58159420A (en) Purification method of interleukin 2
JPS6251589B2 (en)
SU798109A1 (en) Method of producing sorbent for isolating and purifying serine proteases
Orloff et al. Inhibition of fibrin-platelet interactions by fibrinogen-degradation fragment D
Friedman et al. Concentration of parathyroid hormone activity by chromatography on carboxymethylcellulose
JP2722140B2 (en) Method for producing human urinary trypsin inhibitor